Cargando…
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
BACKGROUND: The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic events in COVID-19 patients has been suggested. By using several experimental approaches, we investigated the potential association between SARS-CoV-2 IgGs recognizing the spike (S) protein receptor-binding domain (...
Autores principales: | Gozalbo-Rovira, Roberto, Gimenez, Estela, Latorre, Víctor, Francés-Gómez, Clara, Albert, Eliseo, Buesa, Javier, Marina, Alberto, Blasco, María Luisa, Signes-Costa, Jaime, Rodríguez-Díaz, Jesús, Geller, Ron, Navarro, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459327/ https://www.ncbi.nlm.nih.gov/pubmed/32882666 http://dx.doi.org/10.1016/j.jcv.2020.104611 |
Ejemplares similares
-
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
por: Valdivia, Arantxa, et al.
Publicado: (2021) -
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
por: Olea, Beatriz, et al.
Publicado: (2021) -
Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients
por: Costa, Rosa, et al.
Publicado: (2022) -
The Rotavirus Vaccine Landscape, an Update
por: Cárcamo-Calvo, Roberto, et al.
Publicado: (2021) -
In vitro assessment of the combined effect of letermovir and sirolimus on cytomegalovirus replication
por: Giménez, Estela, et al.
Publicado: (2023)